RIPA, MARCO
 Distribuzione geografica
Continente #
EU - Europa 3.283
NA - Nord America 3.056
AS - Asia 2.306
SA - Sud America 435
Continente sconosciuto - Info sul continente non disponibili 196
AF - Africa 72
OC - Oceania 32
Totale 9.380
Nazione #
US - Stati Uniti d'America 2.834
RU - Federazione Russa 1.712
CN - Cina 711
SG - Singapore 689
IT - Italia 677
BR - Brasile 327
SE - Svezia 294
HK - Hong Kong 292
VN - Vietnam 189
BD - Bangladesh 148
DE - Germania 128
CA - Canada 124
GB - Regno Unito 118
FR - Francia 106
IN - India 71
FI - Finlandia 43
AR - Argentina 41
PL - Polonia 39
MX - Messico 36
NL - Olanda 35
AU - Australia 32
JP - Giappone 32
AT - Austria 30
ES - Italia 28
TR - Turchia 23
ZA - Sudafrica 21
PK - Pakistan 17
SA - Arabia Saudita 17
CO - Colombia 16
ID - Indonesia 16
IQ - Iraq 14
EC - Ecuador 13
TN - Tunisia 13
CR - Costa Rica 12
IR - Iran 12
UA - Ucraina 12
CL - Cile 10
NI - Nicaragua 10
BE - Belgio 9
JM - Giamaica 9
MA - Marocco 9
PH - Filippine 9
TW - Taiwan 9
VE - Venezuela 9
IE - Irlanda 8
KR - Corea 8
PY - Paraguay 8
AE - Emirati Arabi Uniti 7
EG - Egitto 7
HN - Honduras 7
LT - Lituania 7
LU - Lussemburgo 7
UZ - Uzbekistan 7
GT - Guatemala 6
KE - Kenya 6
MY - Malesia 6
PT - Portogallo 6
UY - Uruguay 6
HR - Croazia 5
CH - Svizzera 4
CY - Cipro 4
IL - Israele 4
RO - Romania 4
SC - Seychelles 4
SV - El Salvador 4
EE - Estonia 3
JO - Giordania 3
LB - Libano 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BM - Bermuda 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
MK - Macedonia 2
MN - Mongolia 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
QA - Qatar 2
TH - Thailandia 2
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
CM - Camerun 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
DM - Dominica 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GP - Guadalupe 1
GY - Guiana 1
HU - Ungheria 1
KZ - Kazakistan 1
LR - Liberia 1
MD - Moldavia 1
MU - Mauritius 1
NG - Nigeria 1
Totale 9.175
Città #
Ashburn 397
Singapore 369
Moscow 313
San Jose 285
Hong Kong 281
Dallas 240
Milan 156
New York 154
Beijing 137
Shanghai 125
Council Bluffs 110
Los Angeles 83
Hefei 78
Lauterbourg 69
Ho Chi Minh City 67
Santa Clara 65
Lawrence 60
Princeton 60
Phoenix 59
Rome 56
Boardman 48
São Paulo 45
Hanoi 38
Munich 38
Montreal 36
Orem 36
Warsaw 33
Denver 29
Chennai 27
Tokyo 27
Helsinki 26
London 26
Toronto 25
Atlanta 24
Houston 22
Nuremberg 21
Seattle 21
Cesano Boscone 20
Genoa 20
Naples 20
Poplar 20
Brooklyn 19
Mexico City 17
Stockholm 17
Chicago 16
Guangzhou 16
Miano 14
Rio de Janeiro 14
Boston 13
Turin 13
Turku 13
Da Nang 12
Washington 12
Buffalo 11
Johannesburg 11
Manchester 11
San Francisco 11
Tianjin 11
Verona 11
Catania 10
Columbus 10
Figino 10
Istanbul 10
Managua 10
Mumbai 10
Wollongong 10
Amsterdam 9
Calgary 9
Falkenstein 9
Frankfurt am Main 9
Lahore 9
Miami 9
San José 9
Ankara 8
Baghdad 8
Bari 8
Barnet 8
Bogotá 8
Bologna 8
Brisbane 8
Huskvarna 8
Pietra Ligure 8
The Dalles 8
Vienna 8
Belo Horizonte 7
Brasília 7
Brussels 7
Curitiba 7
Florence 7
Kassel 7
Kingston 7
Madrid 7
Sydney 7
Tashkent 7
Vancouver 7
Charlotte 6
Haiphong 6
Hangzhou 6
Melbourne 6
Montevideo 6
Totale 4.336
Nome #
Outcomes of non-invasive ventilation as the ceiling of treatment in patients with COVID-19 419
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 222
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 195
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 192
Maraviroc in addition to cART during primary HIV infection: Results from MAIN randomized clinical trial and 96-weeks follow-up 188
Clinical Features and Outcomes of Streptococcus anginosus Group Infective Endocarditis: A Multicenter Matched Cohort Study 171
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses 169
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study 165
The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia 164
48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR Study 161
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 161
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB 158
Biobanking for COVID-19 research 157
Impact of Levofloxacin for Prophylaxis of Pre-engraftment Bloodstream Infections after Allogeneic HSCT: A single-center Matched Analysis in an Endemic Country for Carbapenem-resistant Gram-negative Bacteria 150
Trends of Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates between 2012 and 2023: Results from an Open Italian Cohort 148
Characteristics of HIV pre-exposure prophylaxis users at first PrEP counselling visit: the CSL-PrEP cohort 146
Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: A prospective cohort study 142
High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological Malignancies 141
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 137
One-Year Multidisciplinary Follow-Up of Patients With COVID-19 Requiring Invasive Mechanical Ventilation 135
Cerebral thrombus analysis as a useful diagnostic tool for infective endocarditis in ischemic stroke patients 132
Antibiotic appropriateness for Gram-negative bloodstream infections: impact of infectious disease consultation 129
Allogeneic bone marrow transplantation in HIV people with hematological malignancies: Post-transplant cyclophosphamide to overcome the HLA-matching barrier 129
Cardiac implantable electronic device infections: impact of initiation of antimicrobial treatment before or after device removal on microbiological yield 128
Subclinical myocardial dysfunction in patients recovered from COVID-19 126
Post-neurosurgical Nocardia meningoventriculitis: a case report and review of the literature 123
Clinical characteristics and outcome of infective endocarditis due to Abiotrophia and Granulicatella compared to Viridans group streptococci 120
Circulating cathodic antigen (CCA) urine rapid test for diagnosis of Schistosoma mansoni infestation: preliminary data of a cohort study of Egyptian patients coming from an endemic area 118
Beneficial effects of cART initiated during primary and chronic HIV-1 infection on immunoglobulin-expression of memory B-cell subsets 117
Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase 117
Enhanced immunological recovery with early start of antiretroviral therapy during acute or early HIV infection–results of Italian network of acute HIV infection (Inaction) retrospective study 117
Comprehensive CT study to assess local and systemic involvement in patients with infective endocarditis: experience from a multidisciplinary team of a tertiary referral center 116
High-dose anakinra in addition to standard of care including corticosteroids in patients with severe COVID-19 treated with non-invasive ventilation 116
Frailty as a predictor of mortality in COVID-19 patients receiving CPAP for respiratory insufficiency 116
Combination of High-Dose Daptomycin and Ceftriaxone for Cardiac Implantable Electronic Device Infections: A 10-Year Experience 114
Ceftobiprole for the treatment of infective endocarditis: A case series 114
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 111
The spectrum of covid-19-associated myocarditis: A patient-tailored multidisciplinary approach 111
Invasive fungal infections in patients with COVID-19: a review on pathogenesis, epidemiology, clinical features, treatment, and outcomes 110
Myocardial injury in patients with SARS-CoV-2 pneumonia: pivotal role of inflammation in COVID-19 109
The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry 108
Interleukin 1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study 105
Role of Rehabilitation Department for Adult Individuals With COVID-19: The Experience of the San Raffaele Hospital of Milan 105
Infections after Allogenic Transplant with Post-Transplant Cyclophosphamide: Impact of Donor HLA Matching 104
Bowel perforation in a Covid-19 patient: case report 101
How do I manage a patient with Stenotrophomonas maltophilia infection? 99
Disseminated Mycobacterium chimaera infection favoring the development of Kaposi’s sarcoma: a case report 98
The Elephant in the Room: Secondary Infections and Antimicrobial Use in Patients With COVID-19 96
Predictors of survival in elderly patients with coronavirus disease 2019 admitted to the hospital: derivation and validation of the FLAMINCOV score 95
Genetic characterization of Klebsiella pneumoniae carbapenemase -producing Klebsiella pneumoniae isolates with different susceptibility to ceftazidime/avibactam in patients with blood-stream infections 93
Pulmonary Vascular Thrombosis in COVID-19 Pneumonia 91
Four-year outcome of a PI and NRTI-sparing salvage regimen: maraviroc, raltegravir, etravirine 86
Risk factors for Gram-negative bacterial infection of cardiovascular implantable electronic devices: multicentre observational study (CarDINe Study) 80
LC-MS/MS method for simultaneous determination of linezolid, meropenem, piperacillin and teicoplanin in human plasma samples 79
Estimated glomerular filtration rate trajectories in HIV-infected subjects treated with different ritonavir-boosted protease inhibitors and tenofovir disoproxil fumarate or abacavir 79
Multidrug-resistant bacterial colonization affects postoperative outcomes after pancreaticoduodenectomy 78
Is shorter duration of antibiotic treatment feasible in patients with cardiac implantable electronic device infections undergoing device removal? A propensity-adjusted analysis of a 10-year retrospective cohort 78
Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients 77
Time spent with residual viraemia after virological suppression below 50 HIV-RNA copies/mL according to type of first-line antiretroviral regimen 77
Immunosenescence and hurdles in the clinical management of older HIV-patients 77
Influence of empirical double-active combination antimicrobial therapy compared with active monotherapy on mortality in patients with septic shock: A propensity score-adjusted and matched analysis 77
Dynamics of adaptive and innate immunity inpatients treated during primary human immunodeficiency virus infection: Results from Maraviroc in HIV Acute Infection (MAIN) randomized clinical trial 76
Maraviroc 150mg daily plus lopinavir/ritonavir, a nucleoside/nucleotide reverse transcriptase inhibitor-sparing regimen for HIV-infected naive patients: 48-week final results of VEMAN study 74
Homeostatic model assessment for insulin resistance index trajectories in HIV-infected patients treated with different first-line antiretroviral regimens 73
Usefulness of a hub and spoke TDM-guided expert clinical pharmacological advice program of dalbavancin for optimizing very long-term curative or suppressive treatment of chronic staphylococcal infections 72
Real-life experience with remdesivir for treatment of COVID-19 among older adults: a multicentre retrospective study 72
Eosinophils from Physiology to Disease: A Comprehensive Review 71
Evaluation of ceftazidime/avibactam for serious infections due to multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa 71
Short-term peripheral venous catheter-related bloodstream infections: Evidence for increasing prevalence of Gram-negative microorganisms from a 25-year prospective observational study 71
Impact of surgical timing on survival in patients with infective endocarditis: a time-dependent analysis 69
Cefiderocol therapy among immunocompromised adult patients: a descriptive analysis from a prospective, multicentre cohort study 67
Viral rebound after switch to maraviroc/raltegravir dual therapy in highly experienced and virologically suppressed patients with HIV-1 infection 67
Soluble endothelial protein C receptor (sEPCR) as an inflammatory biomarker in naive HIV-infected patients during ART 66
Pustulosis acuta generalisata following chemotherapy in an HIV-positive patient 63
Influence of empirical double-active combination antimicrobial therapy compared with active monotherapy on mortality in patients with septic shock: A propensity score-adjusted and matched analysis-authors' response 62
Immunological Recovery After 24 Weeks of Antiretroviral Therapy in Patients With X4 Virus During Primary HIV Infection 61
Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection 61
Performance of commonly used genotypic assays and comparison with phenotypic assays of HIV-1 coreceptor tropism in acutely HIV-1-infected patients 60
Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvement. 60
Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection-authors' response 58
Invasive Pulmonary Aspergillosis Complicated by Carbapenem-Resistant Pseudomonas aeruginosa Infection During Pembrolizumab Immunotherapy for Metastatic Lung Adenocarcinoma: Case Report and Review of the Literature 58
Bridging the gap in bloodstream infection management: A survey among non-infectious disease physicians 54
The INfectious DIsease REgistry BIObank (INDI-REBIO): protocol for the design and implementation of a single-centre, prospective registry and biobank in a tertiary care centre in Italy for advancing infectious disease research 54
Rugarli. Medicina interna sistematica 53
Rugarli. Medicina interna sistematica 53
Real-life use of high-dose anakinra in patients with COVID-19 treated with remdesivir 22
Monotherapy vs. combination therapy for Enterococcus faecalis bacteraemia: a target trial emulation 21
Regional sepsis care in Catalonia: comparative insights from a secondary analysis of the European Sepsis Care Survey 14
Totale 9.380
Categoria #
all - tutte 45.328
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.328


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022147 0 0 0 31 13 15 16 13 10 6 7 36
2022/2023482 136 113 22 9 20 63 16 52 14 10 17 10
2023/2024519 17 45 92 37 52 111 11 49 5 17 24 59
2024/20251.433 116 39 41 71 72 146 169 190 195 120 99 175
2025/20265.384 373 276 296 658 486 194 379 442 1.486 359 245 190
2026/20271.345 185 465 245 450 0 0 0 0 0 0 0 0
Totale 9.380